References
Sokka T et al (2007) QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 66:1491–1496
Putrik, P (2012) Inequalities across 46 European countries in clinical eligibility criteria for the start of a first (reimbursed) biologic in patients with rheumatoid arthritis. A&R vol 64, Abstract Supplement
Putrik, P (2012) Inequities in access to biologic DMARDS for patients with rheumatoid arthritis across 46 European countries. A&R Sup
Sokka T et al (2009) Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST RA database. Ann Rheum Dis 68:1666–1672
Atzeni F, Benucci M, Sallì S, Bongiovanni S, Boccassini L, Sarzi-Puttini P (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev 12(5):575–579
Oyoo GO (2011) The ILAR-East Africa initiative: current needs and progress in the globalization of rheumatology. Clin Rheumatol 30:251–253
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ognenovski, V., Arsovska-Nalbanti, M., Chichikj, D. et al. Improving rheumatologic care and education in the Republic of Macedonia: model for rheumatologic education and care in a developing country—ILAR Initiative. Clin Rheumatol 32, 1669–1671 (2013). https://doi.org/10.1007/s10067-013-2292-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2292-5